Association of Apolipoprotein E ε2 With White Matter Disease but Not With Microbleeds
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Background and Purpose— Apolipoprotein E (apoE) alleles (ε2 and ε4) are associated with cerebral amyloid angiopathy, in which white matter disease and microbleeds are prominent features. The role of apoE in patients with microbleeds or white matter disease but no evidence of cerebral amyloid angiopathy has not been elucidated. We studied apoE alleles in relation to white matter disease and microbleeds in patients with transient ischemic attack or ischemic stroke. Methods— We obtained brain MRI scans and apoE genotypes in 334 transient ischemic attack or ischemic stroke patients. Microbleeds were scored on a gradient echo MRI and white matter disease was examined on fluid attenuated inversion recovery MRI using a semiquantitative rating scale. Results— Patients with moderate to severe white matter disease more frequently carried apoE ε2 alleles (25.2% versus 11.3%, P =0.001), but not apoE ε4 (26.6% in apoE ε4 carriers versus 25.9%; P =0.98). Adjustment for traditional risk factors did not modify this relationship (odds ratio, 2.9; 95% confidence interval, 1.5 to 5.3). There was no association between the presence of microbleeds and the apoE ε4 or apoE ε2 alleles. Conclusions— ApoE alleles do not exert a major influence on the development of microbleeds, but apoE ε2 may be associated with development of moderate to severe white matter disease in transient ischemic attack and stroke patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cognitive dysfunction in patients with cerebral microbleeds on T2*-weighted gradient-echo MRI
Werring, D. J. (2004) · Brain · doi:10.1093/brain/awh253 · Cited by 421
Jeerakathil, T., Wolf, P. A., Beiser, A., Hald, J. K., Au, R., Kase, C. S., Massaro, J. M., & DeCarli, C. (2004) · Stroke · doi:10.1161/01.str.0000131809.35202.1b · Cited by 319
Association of apolipoprotein E ϵ2 and vasculopathy in cerebral amyloid angiopathy
Greenberg, S. M., Vonsattel, J.-P. G., Segal, A. Z., Chiu, R. I., Clatworthy, A. E., Liao, A., Hyman, B. T., & Rebeck, G. W. (1998) · Neurology · doi:10.1212/wnl.50.4.961 · Cited by 267
McCarron, M. O., Nicoll, J. A. R., Stewart, J., Ironside, J. W., Mann, D. M. A., Love, S., Graham, D. I., & Dewar, D. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199907000-00005 · Cited by 160
APOE ε2/ε4 polymorphism and cerebral microbleeds on gradient-echo MRI
Kim, M., Bae, H. J., Lee, J., Kang, L., Lee, S., Kim, S., Lee, J. E., Lee, K. M., Yoon, B. W., Kwon, O., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000183311.48144.7f · Cited by 39
Cited by
The Microbleed Anatomical Rating Scale (MARS): Reliability of a tool to map brain microbleeds
Gregoire, S. M., Chaudhary, U. J., Brown, M. M., Yousry, T. A., Kallis, C., Jäger, H. R., & Werring, D. J. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c34a7d · Cited by 846
Alzheimer's disease as homeostatic responses to age-related myelin breakdown
Bartzokis, G. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.08.007 · Cited by 546
“…effect of ApoE2 (Bartzokis et al., 2006a, 2007a; lacker et al., 2007) is observed despite an apparent increased isk for vascular ischemic changes associated with this allele Lemmens et al., 2007; Schmidt et al., 1997) that would end to “mask” its beneficial effects on myelin repair and ognition.”
Cordonnier, C., Potter, G. M., Jackson, C. A., Doubal, F., Keir, S., Sudlow, C. L. M., Wardlaw, J. M., & Salman, R. A.-S. (2009) · Stroke · doi:10.1161/strokeaha.108.526996 · Cited by 385
Fernández-Calle, R., Konings, S. C., Frontiñán-Rubio, J., García-Revilla, J., Camprubí-Ferrer, L., Svensson, M., Martinson, I., Boza-Serrano, A., Venero, J. L., Nielsen, H. M., et al. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00566-4 · Cited by 278
Effects of APOE Genotype on Brain Proteomic Network and Cell Type Changes in Alzheimer's Disease
Dai, J., Johnson, E. C. B., Dammer, E. B., Duong, D. M., Gearing, M., Lah, J. J., Levey, A. I., Wingo, T. S., & Seyfried, N. T. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00454 · Cited by 62
“…observation that E2 carriers have a larger burden of white matter hyperintensities on MRI compared to E3 and E4 carriers (Schmidt et al., 1997; Lemmens et al., 2007; Raz et al., 2012; Schilling et al., 2013)—which are often considered to reflect vascular pathology and/or myelination…”
Background
Metadata
- Authors
- Lemmens, R., Görner, A., Schrooten, M., & Thijs, V.
- Venue
- Stroke
- Published
- 2007-04
- Volume
- 38
- Issue
- 4
- Pages
- 1185-1188
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2142562348
- Cited by
- 37
- References
- 5
- FWCI
- 2.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Association of Apolipoprotein E ε2 With White Matter Disease but Not With Microbleeds. https://app.cochat.ai/papers/10.1161/01.str.0000259816.31370.44
- The paper
- Lemmens, R., Görner, A., Schrooten, M., & Thijs, V. (2007). Association of Apolipoprotein E ε2 With White Matter Disease but Not With Microbleeds. Stroke. https://doi.org/10.1161/01.str.0000259816.31370.44
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.